Country music fans and the world mourned the loss of Toby Keith, the iconic singer-songwriter who passed away on Monday night at the age of 62. His death came after a battle with stomach cancer, a diagnosis he had publicly shared over two years prior. This news has not only saddened fans but also brought renewed attention to stomach cancer, prompting medical professionals to emphasize the importance of awareness and early detection.
Toby Keith, known for his patriotic anthems and chart-topping hits, had revealed his stomach cancer diagnosis in June 2022. In a message to his fans on X (formerly Twitter), he explained that he had been diagnosed in the fall of 2021 and had already undergone an intensive treatment regimen. This included chemotherapy, radiation, and surgery, showcasing his proactive approach to fighting the disease from the outset.
Despite the aggressive treatments, Keith remained transparent about his health journey. In June of the following year, 2023, he provided an update to The Oklahoman newspaper, offering a glimmer of hope. He shared that his tumor had shrunk by a third, a testament to the ongoing medical interventions he was receiving. He continued with chemotherapy and also incorporated immunotherapy into his treatment plan. Immunotherapy is a type of treatment that works by stimulating the body’s own immune system to fight cancer cells more effectively.
The news of Toby Keith’s passing has resonated deeply, particularly among the medical community. Doctors are using this moment to highlight the often-overlooked signs and symptoms of stomach cancer. These symptoms can be subtle and easily dismissed, which can unfortunately lead to delayed diagnoses. Common indicators include persistent heartburn, acid reflux, unexplained anemia, nausea, the development of ulcers, pain after eating, sudden and unintentional weight loss, or a sensation of fullness even after consuming only a small amount of food.
Dr. Fabian Johnston, a leading expert in gastrointestinal oncology at Johns Hopkins Medicine, points out the deceptive nature of these symptoms. “A lot of these things are relatively innocuous. But of course with a cancer, that’s how it gets you,” he stated. The tendency for both patients and doctors to overlook these seemingly minor complaints as harmless can significantly delay the diagnostic process. By the time noticeable symptoms manifest, stomach cancer is often in a more advanced stage, making treatment more challenging.
While stomach cancer can affect anyone, certain demographic patterns exist. The average age at diagnosis is around 68 years old. Interestingly, men are slightly more susceptible to developing stomach cancer compared to women. According to the American Cancer Society, it is estimated that approximately 27,000 new cases of stomach cancer will be diagnosed in the United States this year. Despite this significant number, stomach cancer remains relatively uncommon, accounting for about 1.5% of all new cancer diagnoses annually in the U.S.
)
In a somewhat paradoxical trend, overall rates of stomach cancer diagnoses have seen a slight decrease over the past decade. However, a concerning counter-trend is emerging: rates of stomach cancer are actually increasing among adults under the age of 50. The reasons behind this rise in younger adults are not yet fully understood, prompting ongoing research and investigation.
Dr. Ben Schlechter, a gastrointestinal medical oncologist at Dana-Farber Cancer Institute in Boston, highlights this puzzling phenomenon. “There’s something that’s going on — something we’re eating, something we’re ingesting, some combination of factors that’s modern and present — which is resulting in these increased cancers in young people,” he suggests. This points towards potential environmental or lifestyle factors that are contributing to this worrying trend in younger populations.
Historically, risk factors for stomach cancer included alcohol consumption and tobacco use. However, these factors are now associated with a smaller proportion of stomach cancer cases in the United States, possibly due to declining smoking rates. Instead, a significant number of new stomach cancer cases are being linked to chronic acid reflux and infections caused by Helicobacter pylori (H. pylori) bacteria. H. pylori infection can lead to chronic inflammation in the stomach lining. While these conditions are recognized as potential risk factors, the precise reasons why some individuals with these conditions develop stomach cancer while the majority do not remain unclear.
Dr. Schlechter poignantly describes the current understanding of many stomach cancer cases, stating, “for many patients right now, it’s a disease of bad luck.” He acknowledges the potential associations with H. pylori infection and a history of heartburn or reflux, but emphasizes that “usually it’s not as clear,” highlighting the complex and often idiopathic nature of the disease.
Compared to some other types of cancer, stomach cancer is generally considered to be aggressive. Dr. Schlechter clarifies, “It doesn’t mean that people are imminently dying. It just means that the tools that we have to cure them are pretty limited.” While treatment outcomes have improved compared to 15 years ago, the prognosis is still not as favorable as for cancers like breast cancer, where a large majority of patients achieve a cure with current treatments.
The most prevalent type of stomach cancer, accounting for up to 95% of cases in the U.S., is adenocarcinoma. Adenocarcinomas originate in the innermost lining of the stomach. From this initial site, the cancer can spread deeper into the stomach wall, the main body of the stomach, and to nearby lymph nodes.
For patients whose stomach cancer has not yet spread to distant sites, treatment approaches often involve surgery, chemotherapy, immunotherapy, or a combination of these modalities, according to Dr. Rutika Mehta, a medical oncologist specializing in gastrointestinal cancers at Moffitt Cancer Center in Tampa, Florida. In cases where the cancer is more advanced and has metastasized, Dr. Mehta explains that a “cure” is not yet attainable with current medical capabilities. However, treatments like chemotherapy and immunotherapy can still play a crucial role in extending patients’ lives and improving their quality of life.
Significant progress is being made in personalized cancer medicine for stomach cancer. Doctors are increasingly able to identify specific proteins associated with individual stomach cancers, allowing for more targeted treatment strategies. One example is the HER2 gene, which is overexpressed in some stomach cancers, similar to its role in certain types of breast cancer. Dr. Schlechter notes the exciting application of targeted therapies: “The drugs that work in HER2 breast cancer to some degree work in HER2 gastric cancer. So we can now give those drugs to people with stomach cancer and substantially boost their benefit from treatment.”
While Dr. Schlechter acknowledges that the overall outcomes for stomach cancer remain “generally poor,” he emphasizes a crucial point of progress: they are “much better than they used to be.” The ongoing research and advancements in treatment offer hope for improved outcomes and a brighter future for those facing this challenging disease. Toby Keith’s brave fight against stomach cancer serves as a reminder of the importance of early detection, continued research, and unwavering support for those affected by this disease.
